Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Female

Explore clinical trials studying Genital Diseases, Female. Study availability and eligibility vary by location and protocol.

7,700 public trials 1,520 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Female trial results

Completed

Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)

NCT06036836

Conditions
Cutaneous Squamous Cell Carcinoma, Endometrial Cancer, Endometrial Neoplasms, +13 more
Locations
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 0643) New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute ( Site 0642) Boston, Massachusetts, United States
  • Rutgers Cancer Institute of New Jersey ( Site 0635) New Brunswick, New Jersey, United States
  • Duke Cancer Institute ( Site 0641) Durham, North Carolina, United States
View all 44 locations
View Trial Details
Completed

Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])

NCT03517449

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Arizona Oncology Associates, PC- HAL Phoenix, Arizona, United States
  • University of California San Francisco San Francisco, California, United States
  • University of California Los Angeles Santa Monica, California, United States
  • Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
View all 169 locations
View Trial Details
Completed

Study of DF6215 in Patients With Advanced Solid Tumors

NCT06108479

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +42 more
Locations
  • The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States
  • University of California Irvine Medical Center Orange, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 21 locations
View Trial Details
Completed

Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

NCT04539327

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Hospital Torrecárdenas Almería, Andalusia, Spain
  • Hospital Universitario Virgen de la Victoria Málaga, Andalusia, Spain
  • Hospital Universitario Virgen del Rocío Seville, Andalusia, Spain
  • Hospital Universitario Nuestra Señora de Valme Seville, Andalusia, Spain
View all 23 locations
View Trial Details
Completed

A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

NCT05198804

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • Arizona Oncology Associates (Wilmot HOPE) - USOR Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • University of Colorado Aurora, Colorado, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
View all 22 locations
View Trial Details

Related conditions